Eurobio Scientific signe un accord définitif en vue de l'acquisition de la division « Lab Products » de CareDx dédiée à la transplantation
Eurobio Scientific→CareDx Lab Products division
Apr 16, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Masimo Corporation entered into an Agreement and Plan of Merger to be acquired by Danaher. In the merger, Mobius Merger Sub, Inc., a wholly owned Danaher subsidiary, will merge with and into Masimo, with Masimo surviving as a wholly owned Danaher subsidiary.
If the merger is completed, each share of Masimo common stock outstanding immediately prior to the effective time (excluding shares owned by Danaher, Merger Sub, or Masimo subsidiaries, and excluding dissenting shares) will be converted into the right to receive $180.00 in cash per share, without interest. The proxy also describes a Voting and Support Agreement with Politan Capital Management LP to vote covered shares in favor of the merger.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Eurobio Scientific→CareDx Lab Products division
Apr 16, 2026
Quvara Medical→Becton Dickinson
Apr 15, 2026
Parkview Health→Witham Health Services
Apr 15, 2026
Surgery Partners→Preferred Vascular Group
Apr 15, 2026
Sectra→Oxipit
Apr 15, 2026